SEC Form 4 · accession 0001213900-16-015091
DelMar Pharmaceuticals, Inc. · DMPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lynda Sarah Cranston
Director
Period of report
Jul 18, 2016
Accepted (ET)
Jul 19, 2016 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001498382
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 18, 2016 | J | 48 | $3.20 | A | 48 | I | Note |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
- F2Share are held by J.G. Cranston & Associates, Inc.